Ignite Creation Date:
2025-12-24 @ 6:41 PM
Ignite Modification Date:
2026-04-10 @ 7:57 AM
Study NCT ID:
NCT00366457
Status:
COMPLETED
Last Update Posted:
2017-05-15
First Post:
2006-08-17
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Gemcitabine, Bevacizumab and Erlotinib in Pancreatic Cancer
Sponsor:
Massachusetts General Hospital
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
05-234
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None